Breen Michael Martin

GT Biopharma, Inc. · CEO and Director

Breen Michael Martin is listed in public filings as director, officer: CEO and Director. This Breen Michael Martin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include GT Biopharma, Inc. (GTBP). Investors use Breen Michael Martin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
GT Biopharma, Inc.GTBP$133k100k sharesGrant / ExerciseSep 4, 2025$133.0K100k shares$1.33--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.